HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined treatment of pancreatic cancer with mithramycin a and tolfenamic Acid promotes sp1 degradation and synergistic antitumor activity--letter.

AuthorsTing-Chao Chou
JournalCancer research (Cancer Res) Vol. 71 Issue 7 Pg. 2793; discussion 2794-800 (Apr 01 2011) ISSN: 1538-7445 [Electronic] United States
PMID21447740 (Publication Type: Comment, Letter)
Chemical References
  • Sp1 Transcription Factor
  • ortho-Aminobenzoates
  • tolfenamic acid
  • mithramycin A
  • Plicamycin
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Drug Synergism
  • Humans
  • Pancreatic Neoplasms (drug therapy, metabolism)
  • Plicamycin (administration & dosage, analogs & derivatives)
  • Sp1 Transcription Factor (metabolism)
  • ortho-Aminobenzoates (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: